<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               <BR>11 DESCRIPTION<BR><BR>               <BR>                  <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" width="80%"><BR>                     <caption><BR>Table 4. Description<BR></caption><BR>                     <col width="35%" align="left"/><BR>                     <col width="65%" align="left"/><BR>                     <tbody><BR>                        <tr valign="top"><BR>                           <td styleCode="Botrule Lrule Rrule"><BR>Proprietary Name:<BR></td><BR>                           <td styleCode="Botrule Lrule Rrule"><BR>ONFI<sup>&#174;</sup><BR>                           </td><BR>                        </tr><BR>                        <tr valign="top"><BR>                           <td styleCode="Botrule Lrule Rrule"><BR>Established Name:<BR></td><BR>                           <td styleCode="Botrule Lrule Rrule"><BR>Clobazam<BR></td><BR>                        </tr><BR>                        <tr valign="top"><BR>                           <td styleCode="Botrule Lrule Rrule"><BR>Dosage Forms:<BR></td><BR>                           <td styleCode="Botrule Lrule Rrule"><BR>Tablet and Oral Suspension<BR></td><BR>                        </tr><BR>                        <tr valign="top"><BR>                           <td styleCode="Botrule Lrule Rrule"><BR>Route of Administration:<BR></td><BR>                           <td styleCode="Botrule Lrule Rrule"><BR>Oral<BR></td><BR>                        </tr><BR>                        <tr valign="top"><BR>                           <td styleCode="Botrule Lrule Rrule"><BR>Established Pharmacologic Class of Drug:<BR></td><BR>                           <td styleCode="Botrule Lrule Rrule"><BR>Benzodiazepine<BR></td><BR>                        </tr><BR>                        <tr valign="top"><BR>                           <td styleCode="Botrule Lrule Rrule"><BR>Chemical Name:<BR></td><BR>                           <td styleCode="Botrule Lrule Rrule"><BR>7-Chloro-1-methyl-5-phenyl-1H-1,5 benzodiazepine-2,4(<content styleCode="italics">3H,5H</content>)-dione<BR></td><BR>                        </tr><BR>                        <tr valign="top"><BR>                           <td styleCode="Botrule Lrule Rrule"><BR>Structural Formula:<BR></td><BR>                           <td styleCode="Botrule Lrule Rrule"><BR>                              <paragraph>&#160;&#160;&#160;&#160;&#160;&#160;<renderMultiMedia referencedObject="onfi-01"/><BR>                              </paragraph><BR>                           </td><BR>                        </tr><BR>                     </tbody><BR>                  </table><BR>                  <BR><BR><BR>Clobazam is a white or almost white, crystalline powder with a slightly bitter taste; is slightly soluble in water, sparingly soluble in ethanol, and freely soluble in methylene chloride. The melting range of clobazam is from 182-185Â°C. The molecular formula is C16H13O2N2Cl and the molecular weight is 300.7.<BR>                  Each ONFI tablet contains 5 mg, 10 mg, or 20 mg of clobazam. Tablets also contain as inactive ingredients: corn starch, lactose monohydrate, magnesium stearate, silicon dioxide, and talc.<BR>                  ONFI is also available for oral administration as an off-white suspension containing clobazam at a concentration of 2.5 mg/mL. Inactive ingredients include magnesium aluminum silicate, xanthan gum, citric acid monohydrate, disodium hydrogen phosphate dihydrate, simethicone emulsion, polysorbate 80, methylparaben, propylparaben, propylene glycol, sucralose, maltitol solution, berry flavor, purified water.<BR>               <BR>               <BR>               <BR>                  <BR>                     <BR>onfi-01<BR><BR>                     <BR>                        <BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>